• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A comparison of the epidemiological, clinical and viral characteristics between survivors and deaths infected with human avian influenza a (H7N9) viru

tetano

Editor, Senior Moderator
J Infect. 2013 Aug 16. pii: S0163-4453(13)00239-9. doi: 10.1016/j.jinf.2013.08.007. [Epub ahead of print]
A comparison of the epidemiological, clinical and viral characteristics between survivors and deaths infected with human avian influenza a (H7N9) virus in Zhejiang province, China.
Liu S, Sun J, Cai J, Miao Z, Lu M, Qin S, Wang X, Lv H, Yu Z, Amer S, Chai C.
Source

Department of Infectious Diseases, Zhejiang Provincial Centre for Disease Control and Prevention, 630 Xincheng Road, Binjiang District, Hangzhou, Zhejiang 310051, China.
Abstract
BACKGROUND:

The widespread of avian influenza H7N9 in human, with noticeable high mortality in China has been recognized as a great public health concern.
METHODS:

A retrospective study was performed involving 30 survivors and 10 deaths. Epidemiological, clinical and viral features were compared to determine the risk factors associated with fatal outcome of H7N9 infections.
RESULTS:

The present study proved that age (p=0.021), smoking (p=0.04), underlying medical background (p=0.05) and chronic drug use (p=0.042) had a strong relationship with death due to H7N9 infection. The biochemical markers of the sera were higher in the deaths compared to those survivors. Acute respiratory distress syndrome (100%), respiratory failure (100%), co-infection with bacteria (60%); shock (50%) and congestive heart failure (50%) were most the common complications in the deaths. The median time from onset of symptoms to antiviral therapy was 4.6 and 7.4 days among the survivors and deaths, respectively (p=0.04). Viral HA, NA and MP nucleotide sequences of isolates from both study groups showed high homology.
CONCLUSIONS:

Age along with smoking rate, chronic lung disease, immunosuppressive disorders, chronic drug use and delayed Oseltamivir treatment are the high risk factors which might contribute to the observed fatal outcomes in human H7N9 infection.

? 2013 Published by Elsevier Ltd on behalf of The British Infection Association.
KEYWORDS:

Avian influenza A (H7N9) virus, Clinical symptoms, Epidemiology, Fatal outcome

PMID:
23958687
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23958687
 
Back
Top Bottom